Latest News and Press Releases
Want to stay updated on the latest news?
-
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early...
-
Agreement with FDA on Phase II/III trial design positions the Company to exploit eftilagimod alpha’s potential to address high unmet need for metastatic breast cancer patientsPatient population...
-
CHICAGO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The Museum of Broadcast Communications in collaboration with Universal Brand Development, Saturday Night Live, Broadway Video Enterprises and Premier...